ABAnton Bershak

Anton Bershak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Anton Bershak has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 18 November 2026
    • Published by MDPI AG in Preprints.org
      • https://doi.org/10.20944/preprints202611.1861.v1
    Open Access

    Benzo[f][1,2,4]triazino[2,3-d][1,4]diazepine-2,7(6H,8H)-diones: Central GABAergic and Serotonergic Effects in Rats and Docking at the GABAA Receptor Benzodiazepine Site

    by Anton Bershak, Lyudmyla Antypenko, Svitlana Koptieva, Natalia Bohdan, Igor Belenichev, Nina Bukhtiyarova, Iryna Halabitska, Pavlo Petakh, Oleksandr Kamyshnyi, Sergiy Okovytyy, et al.

    The benzo[f][1,2,4]triazino[2,3-d][1,4]diazepine-2,7(6H,8H)-dione system fuses the 1,4-benzodiazepine framework to a nitrogen-rich triazinone ring, and no member has been evaluated pharmacologically. We asked whether the series is centrally active in rats and whether the scaffold is accommodated at the receptor’s benzodiazepine site. Forty-seven derivatives were docked blind against eight human GABAA receptor cryo-electron microscopy structures and profiled with SwissADME and ProTox-3.0. Six members of series 1 were prepared, four as regioisomer mixtures quantified by two methods. Male Wistar rats (n = 10 per group) received a nominal 10 mg/kg intragastrically, delivering 7.1–9.9 mg/kg of the major regioisomer, in the thiopental-induced sleep test and a predator-odour model of post-traumatic stress disorder. Five compounds prolonged thiopental-induced sleep by 30.6–72.2%, and 1.5 and 1.7 shortened sleep-onset latency by 32.4% and 31.1%. Stress reduced cortical GABA 3.65-fold; 1.5 restored it to a level indistinguishable from intact animals. All compounds except 1.1 raised the cortical serotonin transporter Slc6a4, which diazepam did not. Docking identified a C-3 aryl substituent as the dominant affinity determinant, and 1.1, the only C-3 methyl compound tested, was least active in all three readouts. Members of this series are therefore centrally active in rats, with GABAergic and serotonergic components; benzodiazepine-site mediation remains a docking-based hypothesis.